AI in Neurology Market Size to Reach USD 5,619.9 Million by 2034 at a 25.0% CAGR from 2026 to 2034
AI in neurology industry size is estimated at USD 759.2 million in 2025 and forecasted to reach USD 5,619.9 million in 2034 with a CAGR of 25.0%. The AI in neurology market is expanding rapidly driven by increasing adoption of artificial intelligence in neurological diagnostics and treatment planning.
Key Statistics:
- Market Size (2025): USD 759.2 Million
- Market Size (2034): USD 5,619.9 Million
- CAGR (2026-2034): 25.0%
- Dominating Region: North America
Report Highlights:
- Deep learning segment dominated in 2025 with 44.6% revenue due to strong capability in processing complex neurological data.
- Machine learning segment is expected to grow rapidly at CAGR of 25.6% increasing adoption of AI-driven predictive analytics and neurological disease detection.
- Diagnostics segment held 40.5% share in global market due to increasing use of AI in neuroimaging and disease detection.
- Drug discovery segment is projected to grow at a fast pace of 25.4% CAGR supported by rising use of AI in therapeutic development.
- North America dominated the market by 40.63% revenue share due to strong AI adoption across hospitals and advanced healthcare infrastructure.
What’s Included in AI in Neurology Report?
The report provides a detailed overview of the AI in neurology market based on technology, application, and end-user. It includes regional analysis, industry dynamics, and competitive landscape. The study also covers AI model development, neuroimaging applications, and adoption across hospitals and pharmaceutical companies.
What are Driving Factors and Emerging Trends of AI in Neurology Market?
As per analysis, the market is expanding due to increasing burden of neurological disorders and rising demand for advanced diagnostic solutions. Key growth factors include:
- Growth in the Occurrence of Neurological Disorders: Growing number of patients suffering from Alzheimer’s, Parkinson’s, and other neurological disorders is fueling the adoption of AI-powered diagnostic equipment and monitoring devices.
- Growing Elderly Population: Expanding elderly population is making people more vulnerable to neurological diseases, boosting the need for AI-backed healthcare solutions.
- Development of AI-Driven Drug Discovery: Incorporating AI in drug discovery is speeding up the development process and enhancing the effectiveness of neurology research.
These trends indicate a shift toward data-driven and AI-enabled neurology care systems.
Request a free sample copy or read the full market insights: AI in Neurology Market Report
Which Key Segments are Driving AI in Neurology Market?
By Technology Analysis
Deep learning segment accounted for the largest share in 2025 due to high accuracy in image analysis, pattern recognition, and neurological disease prediction.
By Application Analysis
Diagnostics segment dominated the market in 2025 driven by increasing adoption of AI-powered tools for early detection and assessment of neurological disorders.
Which is Dominating Region in AI in Neurology Market?
North America: North America led the market due to strong adoption of AI technologies in healthcare systems and advanced clinical infrastructure.
Asia Pacific: Asia Pacific is expected to grow at a fast pace driven by increasing healthcare investments, large patient population, and expanding digital health infrastructure.
Where is AI in Neurology Market Headed?
According to analysis, the market is expected to witness strong growth supported by increasing integration of AI in healthcare systems, rising demand for early diagnosis, and continuous advancements in neuroimaging and data analytics technologies.
What AI in Neurology Market Report Reveals?
- What is the global market size, growth trend, and CAGR for the AI in neurology market through 2034?
- What are the key factors driving the growth of the AI in neurology market?
- Who are the major companies operating in the AI in neurology market, and how are they positioned competitively?
- How is increasing disease burden influencing AI adoption in neurology?
- What role does AI play in drug discovery and diagnostics?
- What are the key regional trends across North America, Europe, and Asia Pacific?
- Where do new opportunities arise in the AI in neurology market?
Who are Major AI in Neurology Market Contributors?
According to our study, a few firms are leading in the global market. The following are some of the major market contributors:
- Activ Surgical
- Airamed GmbH
- Brainomix Limited
- BrainQ Technologies Ltd.
- Canon Inc.
- GE Healthcare
- Koninklijke Philips N.V.
- Medtronic Plc
- Neosoma Inc.
- Neuralink Corporation
- Neurox
- NVIDIA Corporation
- Qure.AI
- Siemens Healthineers AG
- Viz.ai Inc.
Market Segments Covered
By Technology Outlook (Revenue, USD Million, 2021-2034)
- Deep Learning
- Machine Learning
- NLP
- Others
By Application Outlook (Revenue, USD Million, 2021-2034)
- Diagnostics
- Drug Discovery
- Neurosurgery
- Others
By End-User Outlook (Revenue, USD Million, 2021-2034)
- Hospitals
- Research Institutes
- Pharma Companies
- Others
By Regional Outlook (Revenue, USD Million, 2021-2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of Middle East & Africa
